Key result
Tricuspid valve replacement during the first trimester for mechanical valve thrombosis resulted in favourable maternal and foetal outcomes after failed medical therapy.
Why the study?
Pregnant women with mechanical valves face high maternal and foetal risks, and there is limited data surrounding the best management strategy for mechanical valve thrombosis during pregnancy.
Does tricuspid valve replacement with cardiopulmonary bypass improve maternal and foetal outcomes in a pregnant woman with mechanical tricuspid valve thrombosis?
Case Report (n=1)
Does tricuspid valve replacement with cardiopulmonary bypass improve maternal and foetal outcomes in a pregnant woman with mechanical tricuspid valve thrombosis?
Cardiac surgery with cardiopulmonary bypass for mechanical tricuspid valve thrombosis during the first trimester of pregnancy can result in favourable maternal and foetal outcomes when medical therapy fails.
Answers are grounded in this paper and cite their sources.
May warrant consideration after failed medical therapy in first-trimester mechanical tricuspid thrombosis; leaves open need for prospective safety data.
BACKGROUND: Pregnant women with mechanical valves are considered a high-risk pregnancy. They carry an increased risk of both maternal and foetal complications. This includes maternal valve thrombosis, foetal embryopathy, and haemorrhage. Cardiac surgery is generally avoided during pregnancy, and is used when there are no other alternative options. Cardiopulmonary bypass (CPB) during pregnancy is associated with high foetal mortality. Maternal mortality in the setting of CPB however, is not dissimilar to a non-pregnant woman. CASE SUMMARY: We present the case of a 29-year-old woman with Ebstein's anomaly who developed thrombosis of her mechanical tricuspid valve at 4 weeks' gestation. This was suspected to be likely due to sub-therapeutic anticoagulation at the time of presentation. She underwent a tricuspid valve replacement during the first trimester of pregnancy after failing medical therapy, with overall favourable maternal and foetal outcomes. DISCUSSION: Valve thrombosis during pregnancy is a devastating complication. There is limited data surrounding the best management strategy of valve thrombosis in pregnancy. Cardiac surgery with CPB is reserved for cases refractory to appropriate medical therapy. Though maternal mortality is largely unaffected, foetal mortality with CPB remains high. The management of pregnant women undergoing CPB is unique and extremely challenging. It requires a meticulous, multidisciplinary approach to improve overall outcomes.
No takes yet. Share an insight, caveat, or question.
Sathananthan et al. (2019) conducted a case report in Mechanical tricuspid valve thrombosis during pregnancy (n=1). Tricuspid valve replacement vs. Medical therapy (failed) was evaluated on Maternal and foetal outcomes. Tricuspid valve replacement during the first trimester for mechanical valve thrombosis resulted in favourable maternal and foetal outcomes after failed medical therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: